Publicaciones en colaboración con investigadores/as de University of Tübingen (4)

2024

  1. Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1β production

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Comment on: Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3: Reply

    Rheumatology (Oxford, England), Vol. 62, Núm. 5, pp. e168-e169

2022

  1. Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3

    Rheumatology (United Kingdom)

2021

  1. Sensing low intracellular potassium by NLRP3 results in a stable open structure that promotes inflammasome activation

    Science Advances, Vol. 7, Núm. 38